NCT07217509
PPDTM CorEvitasTM Myasthenia Gravis (MG) Drug Safety and Effectiveness Registry
Enrolling by Invitation
Not specifiedAges 18+ObservationalCorEvitasGovernment-funded
~1,500 participants
Updated 2025-10-16 on ClinicalTrials.gov
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
MG epidemiology
Measured over Every 6 months for 10 years
Conditions
Where it's being run
1 sites across 1 statesMassachusetts1
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
To be eligible to participate in this registry, an individual must meet all the following criteria:
Exclusion
An individual who meets any of the following criteria will be excluded from participation in the registry:
What this trial measures
- MG epidemiologyEvery 6 months for 10 years
The major clinical outcome include an assessment of the epidemiology of Myasthenia Gravis; to better understand the presentation and natural history. This will be determined using PROs and ClinROs which will be included as part of the case report forms.